Zobrazeno 1 - 10
of 47
pro vyhledávání: '"C Gómez-Peña"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
R Morón-Romero, S Ruiz-Fuentes, C García-Fernandez, S. Belda-Rustarazo, C Gómez-Peña, P Gómez-Nieto
Publikováno v:
Eur J Hosp Pharm
Background The prescriptions of biologics are increasing as new indications and drugs are authorised. Since biosimilar drugs were introduced in the pharmaceutical market, they have become an alternative to continuing with the demand at competitive co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09bb1fd73e7a5ef79e21479009ea8609
https://europepmc.org/articles/PMC7535604/
https://europepmc.org/articles/PMC7535604/
Autor:
A Rodriguez Delgado, S Belda Rustarazo, C García Fernández, Mdc Gonzalez Medina, P Nieto Gómez, I Casas Hidalgo, C Gómez Peña
Publikováno v:
Other hospital pharmacy topics.
Background In different clinical studies, the use of botulinum toxin has shown a reduction in health spending, reducing the number of drugs used for patients and decreasing the number of doctor visits and the frequency of episodes. Purpose To analyse
Publikováno v:
European Journal of Hospital Pharmacy. 20:129-131
We report six cases of hyponatraemia secondary to heart failure and cirrhosis that were corrected after oral administration of crystallised urea (30 g/day in all patients). A marked clinical improvement was observed after
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
C Gómez-Peña, C García Fernández, M Valle Corpas, R Morón Romero, J Cabeza-Barrera, Mdc Gonzalez Medina, CL Dávila Fajardo, X Díaz-Villamarín, I Casas Hidalgo, Clara Marin
Publikováno v:
European Journal of Hospital Pharmacy. 23:A30.2-A31
Background Fampridine has been approved for improvement in walking capacity (WC) in multiple sclerosis adult patients with Expanded Disability Status Scale (EDSS) score of 4–7. Purpose To evaluate the effectiveness of fampridine in WC in MS patient
Autor:
R Morón Romero, J Cabeza Barrera, Mdc Gonzalez Medina, C García Fernández, C Gómez Peña, I Casas Hidalgo, M Valle Corpas
Publikováno v:
European Journal of Hospital Pharmacy. 23:A84.2-A85
Background Medication reconciliation (MR) is known to minimise medicine errors and reduce morbidity in hospitalised patients. This process aims to identify and solve unintended medicine discrepancies, defined as differences between the home treatment
Autor:
A Rodriguez Delgado, C Gómez Peña, A Valle Ruiz de la Guardia, R Morón Romero, M Valle Corpas, A Caballero Romero, Mdc Gonzalez Medina, J Cabeza Barrera
Publikováno v:
European Journal of Hospital Pharmacy. 23:A212.1-A212
Background Oncology patients often have swallowing problems or dysphagia. Dysphagia is a frequent syndrome in patients with tumours involving the CNS, head and neck, and upper aerodigestive tract. This can be the initial symptom or related to the onc
Autor:
R Morón Romero, M Valle Corpas, I Casas Hidalgo, C García Fernández, Mdc Gonzalez Medina, S Belda Rustarazo, C Gómez Peña, S Ruiz Fuentes
Publikováno v:
European Journal of Hospital Pharmacy. 23:A88.2-A89
Background Administration of immunosuppressive drugs can cause reactivation of hepatitis B virus (HBV), both asymptomatic and fulminant hepatitis. In July 2014, the Spanish Agency for Medicines and Health Products (AEMPS) published a press release in
Autor:
M Cantudo-Cuenca, C Haro Márquez, M González-Medina, C Gómez-Peña, AM Tristancho-Pérez, E Calvo-Cidoncha, R Morillo Verdugo
Publikováno v:
European Journal of Hospital Pharmacy. 22:A4.2-A5
Background Comorbid chronic conditions have increased among HIV-infected patients. Little work has studied adherence rates for long-term medicines (LTMs). Purpose To assess adherence to other LTMs (non-antiretroviral therapy) among HIV-infected patie